Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation
← catalyst calendarSponsored by Amorepacific Corporation (industry) · 090430.KS — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Randomized · Double · Other
Enrollment
84estimated
Sites
3
Country
South Korea
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-08-08 | actual | When the study began enrolling |
| Primary completion | 2024-12-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2024-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2024-09-19 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-09-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Blood Sugar
Interventions
- Dietary supplement: GTE
- Dietary supplement: Placebo
Primary outcome
what the primary-completion date above is the date OFChange in fasting glucose level
measured Baseline, week 12
Permalink · 090430.KS's whole pipeline · Catalyst calendar · Every registered study · What changed